排序方式: 共有107条查询结果,搜索用时 15 毫秒
61.
62.
63.
进入2009年,中药材周期性的价格调整和世界金融危机的巨大影响叠加重合,使多年来居高不下中药材大盘急转直下。从2008年下半年开始,价格纷纷跳水的中药材品种如雨后春笋,很多品种跌势如铁,落幅之大、落速之快令持货商始料不及。2009年春节过后,全国各市场一改年前的低迷沉闷,小批量货源走动畅快,部分品种年后价格有所回升,市场状况并不像人们预想的那样糟糕, 相似文献
64.
65.
66.
应用PDCA循环法分析物价调整过程中可能出现的问题及相关因素,采取应对措施,使价格调整工作平稳实施,患者及家属对物价调整理解和支持,未发生物价方面的投诉及纠纷. 相似文献
67.
68.
69.
Background Under the circumstance of the New Medical Reform in Mainland of China,lowering drug prices has become an approach to relieving increase of medical expenses,and lowering brand-name medication price is a key strategy.This study,by comparing and analyzing brand-name medication prices between Mainland of China and Taiwan,explores how to adjust brand-name medication prices in Mainland of China in the consideration of the drug administrative strategies in Taiwan.Methods By selecting brand-name drug with generic name and dose types matched in Mainland and Taiwan,calculate the average unit price and standard deviation and test it with the paired t-test.In the mean time,drug administrative strategies between Mainland and Taiwan are also compared systematically.Results Among the 70 brand-name medications with generic names and matched dose types,54 are at higher prices in Mainland of China than Taiwan,which is statistically significant in t-test.Also,among the 47 medications with all of matched generic names,dose types,and manufacturing enterprises,38 are at higher prices in Mainland than Taiwan,and the gap is also statistically significant in t-test.In Mainland of China,brand-name medication took cost-plus pricing and price-based price adjustment,while in Taiwan,brand-name medication took internal and external reference pricing and market-based price adjustment.Conclusions Brand-name drug prices were higher in Mainland of China than in Taiwan.The adjustment strategies of drug orices are scientific in Taiwan and are worth reference by Mainland of China. 相似文献
70.